Does a diabetes shot help keep people out of the hospital?

Original Title

Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

A special weekly shot for diabetes called exenatide helps some people live longer and avoid repeat heart failure hospital stays—but only if they don’t already have heart failure.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

The drug cuts repeat heart failure hospitalizations but not the first one.

Most treatments aim to prevent the first major event. Here, exenatide failed to stop the initial hospitalization but significantly reduced repeat visits—a rare and counterintuitive pattern.

Practical Takeaways

If you have type 2 diabetes and a healthy heart, ask your doctor if a GLP-1 RA like exenatide could help lower your risk of death.

high confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

95%
High QualityOverall Score

Publication

Journal

Circulation

Year

2019

Authors

M. Fudim, Jennifer A. White, N. Pagidipati, Y. Lokhnygina, J. Wainstein, J. Murín, N. Iqbal, P. Öhman, R. Lopes, B. Reicher, R. Holman, Adrian F. Hernandez, R. Mentz

Open Access
77 citations
Analysis v1